Males Found to be More Susceptible to Respiratory Bacterial Infections
A 2-year retrospective study looking at patients admitted to the ICU showed that the number of intubated males infected with Acinetobacter baumannii (AB) was double the number of intubated females.
Addressing the Decline in the Number of Infectious Disease Physicians
Recent numbers show a lack of new people entering the field combined with existing shortfalls in many US locations.These factors demonstrate a potentially dangerous reduction in this vital medical specialty.
NIH Awards Grants Toward Diagnosis of COVID-19-Related Inflammatory Syndrome in Children
Research will focus on new technologies for early diagnosis of severe illnesses resulting from SARS-CoV-2 infection.
On the Precipice of the World's First RSV Vaccine: What's Taking so Long?
RSV cases spiked to unprecedented levels this season. Why were these infections so frequent and severe? Why has vaccine development taken so long?
COVID-19 Vaccinations Increased 5.2% This Year. Where Are They Still Lagging?
Good news: across 23 countries, trust in COVID-19 vaccines increased 5.2% from 2021 to 2022. However, vaccine hesitancy remains in key populations.
Moderna Provides Update on mRNA Vaccine Pipeline
The company is moving forward with vaccines to address respiratory and latent viruses as well as oncology.
COVID-19 Prophylactic Evusheld Not Expected to Neutralize New Omicron XBB.1.5 Variant
Evusheld, the only FDA-approved COVID-19 pre-exposure prophylactic, is anticipated to be ineffective against the emerging XBB.1.5 variant.
VV116 Vs Paxlovid Shown to Be Noninferior in Adults at Risk of Severe COVID-19
The investigational antiviral showed the potential of another therapy that could benefit this patient population that is at risk for hospitalization and death.
For Men, Prior COVID-19 Infection May Boost Immune Response to Influenza Vaccination
“This was a total surprise,” said study lead author John Tsang, PhD.
What We Know About XBB.1.5, the New and Highly Contagious Omicron Subvariant
In just a month, the XBB.1.5 variant went from causing 1% to over 40% of new COVID-19 infections.
Cyproheptadine Arm of COVID-19 Treatment Study Terminated
Due to negative results, the I-SPY COVID Trial is no longer evaluating cyproheptadine to treat critically ill COVID-19 patients.
Molnupiravir Doesn’t Decrease COVID-19 Deaths or Hospitalizations, but May Speed Recovery
Despite failing to meet primary trial endpoints, molnupiravir reduced the length of COVID-19 infection by 4.2 days in vaccinated patients.
How the COVID-19 Pandemic Changed State-Level Cigarette Sales
During the COVID-19 pandemic, cigarette sales differed from projected sales volume. One study examined these trends at the state level.
STIs: Neglected During COVID-19
Sexually transmitted infections (STIs) received little attention during the pandemic, but the truth is the STIs did not stop infection increases shortly after the quarantine.
Medical Masks Or N95s For COVID-19 Protection in Health Care?
Although medical masks were noninferior to N95 in a multinational study of frontline health care workers, variability in circumstances between countries prevented researchers from drawing firm conclusions.
Employee Health After the COVID-19 Pandemic: Stronger Than Yesterday
For providers on the front lines, lessons learned can help inform
strategies to enhance the protection of their health going forward.
The Year's Top COVID-19 Stories
New booster shots, antigen testing, and a shrinking incubation period: these were the top COVID-19 stories of 2022.
Why Aren’t We Better Protecting Our Youngest Children Against Infections?
Vaccinations and mitigations for COVID-19 and other respiratory viruses have not been made a priority for young children. Let’s change this before the next big surge hits.
SHEA: Do Not Screen Symptom-Free Patients for COVID-19 Upon Hospital Admission
The new recommendation from the organization believes it will help avoid delays in patient care.
Antimicrobial Prescribing in the Telehealth Setting: Framework for Stewardship During a Period of Rapid Acceleration Within Primary Care
Telemedicine use is likely to continue expanding even as the COVID-19 pandemic slowly resolves.
FDA Approves Monoclonal for COVID-19 Treatment in Hospitalized Adults
Roche’s Actemra is the first FDA approved monoclonal antibody to be used for COVID-19.
FDA Announces Next VRBPAC Looking at Future of COVID-19 Vaccine Regimens
The committee will meet on January 26 to discuss whether and how the composition for primary doses of the currently available COVID-19 vaccines should be modified.
Bivalent Booster Provides Protection Against Severe COVID-19, Possible Hospitalization
In a new CDC report, these immunizations aid against emergency department and urgent care encounters in immunocompetent adults.
The Week's Most Significant COVID-19 Updates
2 years after the COVID-19 vaccine, we're focusing on who is still getting the most severe disease and why.
New Research Shows “Y” Men Are More Likely to Have Severe COVID-19
With these findings, the Uppsala University investigators believe loss of the Y chromosome in white blood cells can predict which patients are at high risk of severe COVID-19 disease progression.
Paxlovid: Reducing the Risk of Hospitalization, Mortality
A large health system saw a reduction of 40% and 70% respectively when the antiviral was prescribed.
CDC: Long COVID Responsible for Over 3500 Deaths
A new report looked at mortality over a 2 ½ year period, and the epidemiology of who was most affected.
Blood-Related Syndrome Is Being Seen After Developing COVID-19 or Vaccination
Postural orthostatic tachycardia syndrome (POTS) is happening in people post-virus as well as within a 90-day period post-vaccination.
2 Years of the COVID-19 Vaccine: How Many Severe and Fatal Infections Have Been Prevented?
In addition to avoiding additional infection, illness, and death, the COVID-19 vaccination program likely saved the US $1.25 trillion in medical costs.
This Week’s Infectious Disease Breaking News
It was a week marked by significant FDA decisions and COVID-19 treatment updates.
2 Clarke Drive Cranbury, NJ 08512